Close Menu

NEW YORK (GenomeWeb) – Tangen Biosciences today announced that it has closed a $9 million Series A equity financing round and will use the proceeds to develop its TangenDx platform for two undisclosed infectious disease tests performed in the clinic.

Tangen said that its platform employs rapid isothermal nucleic acid detection of targeted DNAs and RNAs directly from specimens. The platform may enable use of low cost, portable, and rapid MDx diagnostic capabilities outside traditional laboratories, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.